About Merrybell Bioceuticals
Merrybell Bioceuticals is a company based in Karnal (India) founded in 2012. It operates as a B2B and D2C. Merrybell Bioceuticals offers products and services including Tablets, Capsules, Ointments, Syrups and Suspensions, and Injections. Merrybell Bioceuticals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Karnal, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Xieonlife Sciences Pvt. Ltd.
- Date of Incorporation 14 Feb, 2007
- Jurisdiction Delhi, Delhi, India
-
Annual Revenue
$5.04 M (USD)18.43as on Mar 31, 2024
-
Net Profit
$153.91 K (USD)30.07as on Mar 31, 2024
-
EBITDA
$191.54 K (USD)47.87as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Merrybell Bioceuticals
Merrybell Bioceuticals offers a comprehensive portfolio of products and services, including Tablets, Capsules, Ointments, Syrups and Suspensions, and Injections.
Solid dosage forms for treating various health conditions effectively.
Encapsulated drugs providing targeted treatment for multiple ailments.
Creams and lotions for skin and derma care applications.
Oral liquids for easy administration in pediatric and general care.
Parenteral drugs for specialized treatments like diabetic care.
Funding Insights of Merrybell Bioceuticals
Detailed funding history for Merrybell Bioceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Merrybell Bioceuticals
Investment portfolio details for Merrybell Bioceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Merrybell Bioceuticals
Detailed financials for Merrybell Bioceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Merrybell Bioceuticals Comparisons
Peer comparison for Merrybell Bioceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Merrybell Bioceuticals
Merrybell Bioceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Merrybell Bioceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Merrybell Bioceuticals
Complete news archive for Merrybell Bioceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Merrybell Bioceuticals
Merrybell Bioceuticals was founded in 2012.
Merrybell Bioceuticals is headquartered in Karnal, India. It is registered at Karnal, Haryana, India.
Annual revenue of Merrybell Bioceuticals is $5.04M as on Mar 31, 2024.
MerryBell, established in 2008 in India, specializes in manufacturing and marketing a wide range of pharmaceutical products such as tablets, capsules, ointments, syrups, and injections. The company serves various healthcare categories including general care, orthopedic, and dermatology, emphasizing quality, affordability, and global distribution. It operates from its primary location in Karnal, aiming to alleviate suffering through accessible medicines and innovative solutions for clients across the globe.
Merrybell Bioceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Merrybell Bioceuticals offers Tablets, Capsules, Ointments, Syrups and Suspensions, and Injections.